3.86
Niagen Bioscience Inc Aktie (NAGE) Neueste Nachrichten
NAGE Stock Price, Quote & Chart | NIAGEN BIOSCIENCE INC (NASDAQ:NAGE) - ChartMill
National Advertising Review Board Recommends Niagen Modify or Discontinue Certain Tru Niagen NAD+ Dietary Supplement Claims - The Manila Times
National Advertising Review Board Recommends Niagen Modify - GlobeNewswire
NAGE News | NIAGEN BIOSCIENCE INC (NASDAQ:NAGE) - ChartMill
Niagen Bioscience Earnings Call Highlights Growth Push - TipRanks
How The Niagen Bioscience (NAGE) Story Is Shifting As Price Targets Edge Lower - Yahoo Finance
Is Niagen Bioscience’s (NAGE) Telehealth Niagen Plus Launch a Turning Point in Its Direct-Access Strategy? - simplywall.st
Niagen Bioscience stock price target lowered to $11 by H.C. Wainwright - Investing.com Australia
HC Wainwright Lowers Niagen Bioscience (NASDAQ:NAGE) Price Target to $11.00 - MarketBeat
Assessing Niagen Bioscience (NAGE) Valuation After Earnings Strength And New NAD Plus Delivery Initiatives - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
A Look At Niagen Bioscience (NAGE) Valuation After Q1 2026 Beat And Niagen Plus Telehealth Launch - Sahm
Niagen Bioscience, Inc. Reports First Quarter 2026 Financial Results - Post Register
Q1 2026 Niagen Bioscience Inc Earnings Call Transcript - GuruFocus
Will Niagen Bioscience’s (NAGE) Telehealth NAD+ Push Redefine Its Core Therapeutic Focus? - Yahoo Finance
Biotech Innovator Niagen Uncovers Breakthrough NAD+ Booster, Reports Strong Q1 Results - Streetwise Reports
Niagen Bioscience Announces Participation in Upcoming Investor Conferences - PharmiWeb.com
Niagen Bioscience Announces Participation in Upcoming May 2026 Investor Conferences - BioSpace
Niagen Bioscience Keeps Full-Year Sales Forecast Intact As Q1 Revenue, Profit Climbs (UPDATED) - Sahm
Niagen Bioscience Q1 2026 slides: e-commerce surges 14% amid transition By Investing.com - Investing.com South Africa
Niagen Bioscience Q1 2026 slides: e-commerce surges 14% amid transition - Investing.com Canada
Niagen Bioscience reaffirms 10%-15% 2026 growth outlook while increasing marketing spend expectations - MSN
Niagen Bioscience Inc Q1 2026 Earnings Call Summary - Yahoo Finance
Earnings call transcript: Niagen Bioscience Q1 2026 sees growth in e-commerce By Investing.com - Investing.com South Africa
Niagen Bioscience (NAGE) Q1 Earnings and Revenues Top Estimates - Yahoo Finance
Earnings call transcript: Niagen Bioscience Q1 2026 sees growth in e-commerce - Investing.com UK
Niagen (NAGE) Q1 2026 Earnings Call Transcript - AOL.com
Niagen Bioscience Reports Q1 Results, Updates 2026 Outlook - TipRanks
Niagen Bioscience Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Niagen Bioscience (NASDAQ:NAGE) Shares Slide After Q1 Earnings Miss and Spending Guidance - ChartMill
Niagen Bioscience Inc. (NAGE) Stock Falls on Q1 2026 Earnings - Quiver Quantitative
Niagen Bioscience: Q1 Earnings Snapshot - marketscreener.com
Niagen Bioscience (Nasdaq: NAGE) Q1 2026 sales reach $31.5M with strong margins - Stock Titan
Segment sale lifts Niagen Bioscience (Nasdaq: NAGE) Q1 2026 profit - Stock Titan
Tranche Update on Niagen Bioscience, Inc.'s Equity Buyback Plan announced on November 6, 2025. - marketscreener.com
Niagen Bioscience Is Maintained at Buy by Canaccord Genuity - Moomoo
Niagen Bioscience Price Target Cut to $10.00/Share From $13.00 by Canaccord Genuity - Moomoo
CCORF Maintains Niagen Bioscience(NAGE.US) With Buy Rating, Cuts Target Price to $10 - Moomoo
Niagen Bioscience Inc expected to post earnings of 8 cents a shareEarnings Preview - TradingView
Niagen Bioscience (NAGE) Launches Telehealth Platform for Home D - GuruFocus
Niagen Bioscience launches telehealth platform with at-home kit By Investing.com - Investing.com South Africa
Niagen Bioscience launches telehealth platform with at-home kit - Investing.com UK
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):